Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | -3.78% | -8.67% | -51.72% |
Financials (USD)
Sales 2024 * | 65.3M | Sales 2025 * | 6.25M | Capitalization | 18.66M |
---|---|---|---|---|---|
Net income 2024 * | 26M | Net income 2025 * | -40M | EV / Sales 2024 * | 0.29 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.98 x |
P/E ratio 2024 * |
0.77
x | P/E ratio 2025 * |
-0.49
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on MEI Pharma, Inc.
1 day | -3.78% | ||
1 week | -8.67% | ||
Current month | -2.10% | ||
1 month | -8.50% | ||
3 months | -33.96% | ||
6 months | -56.04% | ||
Current year | -51.72% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 2.8 | -3.78% | 112,428 |
24-06-03 | 2.91 | +1.75% | 30,184 |
24-05-31 | 2.86 | -1.38% | 18,971 |
24-05-30 | 2.9 | -0.68% | 14,837 |
24-05-29 | 2.92 | -4.75% | 34,865 |
Delayed Quote Nasdaq, June 04, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.72% | 18.66M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.33% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- MEIP Stock